腰椎间盘突出症应用经皮椎间孔镜治疗临床疗效分析(1)
[摘要] 目的 应用经皮椎间孔镜治疗腰椎间盘突出症患者，以此分析应用经皮椎间孔镜治疗的临床效果。 方法 方便选择腰椎间盘突出症患者，患者例数100例，时间于：2017年2月—2019年2月，随机分对照组与研究组，对应治疗方式：椎板开窗手术治疗、经皮椎间孔镜治疗。对组间的手术时间、术中出血量、治疗优良率、治疗前后的临床症状评分进行指标对比。结果 就研究组而言，其手术时间(77.32±40.21)min、术中出血量(90.11±4.21)mL与治疗后的临床症状评分(3.22±1.21)分均比对照组手术时间、术中出血量治疗后的临床症状评分分别(97.77±40.11) min、(109.21±5.55) mL、(5.21±1.23)分更低(t=2.55、19.39、8.16，P<0.05)，且其治疗优良率(96.00%)比对照组(76.00%)高，差异有统计学意义(χ2=8.31，P<0.05);研究组、对照组与治疗前相比，治疗后的临床症状评分均差异有统计学意义(P<0.05)。結论 应用经皮椎间孔镜治疗腰椎间盘突出症患者，可以提高患者的临床治疗效果，能够改善患者的临床症状，且缩短了手术时间，降低了患者的出血量，应用安全性十分显著。
[关键词] 腰椎间盘突出症;经皮椎间孔镜;临床疗效;疗效分析
[中图分类号] R687.3 [文献标识码] A [文章编号] 1674-0742(2020)02(b)-0054-03
Clinical Analysis of Percutaneous Transforaminal Endoscopy in the Treatment of Lumbar Disc Herniation
ZHAO Peng-fei， DING Hua-wen， TONG Guo-qiang， LI Wen-jun， LIU Ji-peng
Department of Surgery， Fifth Division Hospital， Xinjiang Construction Corps， Bozhou ，Xinjiang，833400 China
[Abstract] Objective To analyze the clinical effect of percutaneous transforaminal lumbar discectomy with percutaneous transforaminal lumbar disc herniation. Methods Patients with lumbar disc herniation were convenienty selected. The number of patients was 100. The time was from February 2017 to February 2019. They were randomly divided into two groups for treatment. The control group and the study group， respectively， the number of patients in the group. For 50 cases， the corresponding treatment methods： laminectomy treatment， percutaneous transforaminal treatment. The indexes of operation time， intraoperative blood loss， excellent rate of treatment， and clinical symptom scores before and after treatment were compared. Results For the study group， the operation time (77.32±40.21) min， intraoperative blood loss (90.11±4.21) mL and post-treatment clinical symptom score (3.22±1.21) points were all compared with the control group (surgery time， surgery). The clinical symptom scores after treatment for hemorrhagic volume were (97.77±40.11) min， (109.21±5.55)mL，(5.21±1.23) min， respectively(t=2.55， 19.39， 8.16， P<0.05)， and the excellent rate of treatment (96.00%) was higher than the control group (76.00%)， the difference was statistically significant(χ2=8.31， P<0.05，); the clinical symptom scores of the study group and the control group were significantly different after treatment(P<0.05).Conclusion The application of percutaneous transforaminal lumbar disc herniation in patients with lumbar disc herniation can improve the clinical treatment of patients， improve the clinical symptoms of patients， shorten the operation time， reduce the amount of bleeding， and the safety of application is very significant., 百拇医药(赵鹏飞 丁华文 仝国强 李文钧 刘继鹏)
[关键词] 腰椎间盘突出症;经皮椎间孔镜;临床疗效;疗效分析
[中图分类号] R687.3 [文献标识码] A [文章编号] 1674-0742(2020)02(b)-0054-03
Clinical Analysis of Percutaneous Transforaminal Endoscopy in the Treatment of Lumbar Disc Herniation
ZHAO Peng-fei， DING Hua-wen， TONG Guo-qiang， LI Wen-jun， LIU Ji-peng
Department of Surgery， Fifth Division Hospital， Xinjiang Construction Corps， Bozhou ，Xinjiang，833400 China
[Abstract] Objective To analyze the clinical effect of percutaneous transforaminal lumbar discectomy with percutaneous transforaminal lumbar disc herniation. Methods Patients with lumbar disc herniation were convenienty selected. The number of patients was 100. The time was from February 2017 to February 2019. They were randomly divided into two groups for treatment. The control group and the study group， respectively， the number of patients in the group. For 50 cases， the corresponding treatment methods： laminectomy treatment， percutaneous transforaminal treatment. The indexes of operation time， intraoperative blood loss， excellent rate of treatment， and clinical symptom scores before and after treatment were compared. Results For the study group， the operation time (77.32±40.21) min， intraoperative blood loss (90.11±4.21) mL and post-treatment clinical symptom score (3.22±1.21) points were all compared with the control group (surgery time， surgery). The clinical symptom scores after treatment for hemorrhagic volume were (97.77±40.11) min， (109.21±5.55)mL，(5.21±1.23) min， respectively(t=2.55， 19.39， 8.16， P<0.05)， and the excellent rate of treatment (96.00%) was higher than the control group (76.00%)， the difference was statistically significant(χ2=8.31， P<0.05，); the clinical symptom scores of the study group and the control group were significantly different after treatment(P<0.05).Conclusion The application of percutaneous transforaminal lumbar disc herniation in patients with lumbar disc herniation can improve the clinical treatment of patients， improve the clinical symptoms of patients， shorten the operation time， reduce the amount of bleeding， and the safety of application is very significant., 百拇医药(赵鹏飞 丁华文 仝国强 李文钧 刘继鹏)
参见：首页 > 医疗版 > 疾病专题 > 骨科 > 腰痛及颈肩痛 > 腰椎间盘突出症